サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
表紙：世界のマタニティヘルス市場：2023～2030年
市場調査レポート
商品コード
1350998

世界のマタニティヘルス市場：2023～2030年

Global Maternal Health Market 2023-2030

出版日
ページ情報
英文 120 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
世界のマタニティヘルス市場：2023～2030年
出版日: 2023年08月25日
発行: Orion Market Research
ページ情報: 英文 120 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のマタニティヘルス市場は予測期間（2023～2030年）にCAGR 9.0％で成長すると予測されます。同市場の成長は、妊産婦と乳幼児の健康状態の改善につながる、エビデンスに基づくベストプラクティスの採用に対する需要の高まりに起因しています。現在では、患者ケアの質、安全性、妊娠中および産後の患者へのアクセスの面で最高水準を採用している病院には、その施設について消費者に知らせる認証が授与されています。それに伴い、市場各社は新たなプログラムの需要に応えるべく新製品を投入しています。例えば、2022年、メディケア＆メディケイド・サービスセンター（CMS）は、乳児と妊産婦の両方の健康を増進するため、低リスク帝王切開分娩を減らすことを目的としたマタニティ＆ベビーヘルスプログラムの中で新しいプログラムを開始しました。このプログラムの中核は、低リスク帝王切開分娩を予防するための戦略をメディケイドとCHIP機関に提供し、研究によって証明されたベストプラクティスを各州で採用するために各州と直接協力する学習共同体です。

セグメント別の展望

妊娠糖尿病サブセグメントが世界のマタニティヘルス市場でかなりのシェアを占めると予測される

合併症の中でも、妊娠糖尿病サブセグメントは世界の妊産婦健康市場でかなりのシェアを占めると予想されます。このセグメントの成長は、地域全体の人口の間で妊娠糖尿病の有病率が増加していることに起因しています。妊娠糖尿病は、食事療法、運動療法、そして重症度によってはインスリン療法でコントロールすることができます。糖尿病と呼ばれる慢性（長期間続く）病状は、身体が食物をエネルギーに変換する方法に影響を及ぼします。妊娠糖尿病治療の目標は、血糖値を糖尿病のない妊婦と同程度に維持することです。特別な食事療法、定期的な運動スケジュール、毎日の血糖検査、インスリン注射が治療のすべてです。米国疾病予防管理センターによると、糖尿病を患っていない女性でも、妊娠中に妊娠糖尿病を発症する可能性があると言われています。妊娠糖尿病は、米国では毎年妊娠の2％から10％の間に影響を与えます。妊娠糖尿病のコントロールを維持することで、安全な妊娠と健康な出産が保証されます。

地域別展望

世界の妊産婦健康市場は、北米（米国とカナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、南米）を含む地域別にさらに細分化されます。なかでもアジア太平洋地域は、公衆衛生意識の高まりと革新的な医療技術に対する需要の高まりにより、世界全体で突出したシェアを占めると予想されます。

北米地域は世界の妊産婦健康市場において著しいCAGRで成長すると予測される

全地域の中で、北米は予測期間中にかなりのCAGRで成長すると予測されています。同地域の成長は、同地域全体で家族計画に対する需要が高まっていることに起因しています。避妊や家族計画サービスを利用する機会を持つ女性は、妊娠の間隔を空けることができ、困難のリスクを下げることができます。それに伴い、市場関係者は妊産婦死亡率の需要に応える新製品を打ち出しています。疾病対策予防センターによると、この報告書は2018年から2020年までの妊産婦死亡率を示した以前のものを更新したものです。米国では、2020年には861人、2019年には754人であったのに対し、2021年には1,205人の女性が妊娠が原因で亡くなっています。2020年の出生10万人当たりの死亡率が23.8人、2019年の出生10万人当たりの死亡率が20.1人であったのに対し、2021年の妊産婦死亡率は32.9人でした。2021年の非ヒスパニック系黒人（つまり黒人）女性の妊産婦死亡率は、出生10万人当たり69.9人で、非ヒスパニック系白人（つまり白人）女性の死亡率（26.6人）の2.6倍でした。黒人女性の死亡率は、白人女性やヒスパニック系女性の死亡率よりも有意に高かったです。2020年から2021年にかけて、ヒスパニックの血を引く個人と他のすべての人種グループで有意な増加がみられました。

2018年の妊産婦死亡率は出生10万人当たり17.4人、2019年は出生10万人当たり20.1人、2020年は出生10万人当たり23.8人、2021年は出生10万人当たり32.9人でした。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Agile Therapeutics, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Boston MedTech Advisors, Inc.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • MCH Ventures, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • マタニティヘルスの世界市場：タイプ別
    • 子宮内
    • 子宮外
    • 卵管
    • その他（腹腔内妊娠、単胎妊娠、多胎妊娠）
  • マタニティヘルスの世界市場：合併症別
    • 流産
    • 早産と出産
    • 子癇前症
    • 妊娠糖尿病
    • 前置胎盤
    • その他（重度の出血、感染症）
  • マタニティヘルスの世界市場：ケア別
    • 出産前ケア
    • 産後ケア

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Apollo Hospitals Enterprise Ltd.
  • Ann & Robert H. Lurie Children's Hospital of Chicago
  • Cincinnati Children's Hospital Medical Center
  • Fuji Latex Co., Ltd.
  • Jiovio Healthcare
  • Johnson & Johnson Services, Inc.
  • March of Dimes
  • McKinsey & Co.
  • MedTech Boston
  • Merck & Co., Inc.
  • Okamoto Industries Co., Ltd.
  • RAND Corp.
  • Reckitt Benckiser Group
  • Sanofi
図表

LIST OF TABLES

  • 1. GLOBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL INTRAUTERINE MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL ECTOPIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL TUBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL OTHER TYPES OF MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 7. GLOBAL MATERNAL HEALTH FOR MISCARRIAGE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL MATERNAL HEALTH FOR PREMATURE LABOR & BIRTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL MATERNAL HEALTH FOR PREECLAMPSIA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL MATERNAL HEALTH FOR GESTATIONAL DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL MATERNAL HEALTH FOR PLACENTA PREVIA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL MATERNAL HEALTH FOR OTHER COMPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 14. GLOBAL PRENATAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL POSTNATAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. EUROPEAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 23. EUROPEAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 24. EUROPEAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 27. ASIA- PACIFIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 28. ASIA- PACIFIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MATERNAL HEALTH MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL INTRAUTERINE MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL ECTOPIC MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL TUBAL MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL OTHER TYPES OF MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL MATERNAL HEALTH MARKET SHARE BY COMPLICATION, 2022 VS 2030 (%)
  • 7. GLOBAL MATERNAL HEALTH FOR MISCARRIAGE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL MATERNAL HEALTH FOR PREMATURE LABOR & BIRTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL MATERNAL HEALTH FOR PREECLAMPSIA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL MATERNAL HEALTH FOR GESTATIONAL DIABETES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL MATERNAL HEALTH FOR PLACENTA PREVIA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL MATERNAL HEALTH FOR OTHER COMPLICATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL MATERNAL HEALTH MARKET SHARE ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 14. GLOBAL PRENATAL MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL POSTNATAL MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. US MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. CANADA MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. UK MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. FRANCE MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. GERMANY MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. ITALY MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SPAIN MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF EUROPE MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. INDIA MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. CHINA MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. JAPAN MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. SOUTH KOREA MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF ASIA-PACIFIC MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027591

Title: Global Maternal Health Market Size, Share & Trends Analysis Report by Type (Intrauterine, Ectopic, Tubal, and Others), by Complication (Miscarriage, Premature Labor & Birth, Preeclampsia, Gestational Diabetes, Placenta Previa, and Others), and by care (Prenatal Care, and Postnatal Care),Forecast Period (2023-2030).

The global Maternal Health market is anticipated to grow at a CAGR of 9.0% during the forecast period (2023-2030). The growth of the market is attributed to the growing demand for adopting evidence-based best practices that can lead to better maternal and infant health outcomes. Nowadays, hospitals that have adopted the highest standards in terms of patient care quality, safety, and accessibility for pregnant and postpartum patients have been awarded a certification that informs consumers about the establishments. Accordingly, market players are coming up with new products to cater to the demand for new programs. For instance, in 2022, the Centers for Medicare & Medicaid Services (CMS) launched a new programme within its maternity and baby health programme aimed at reducing low-risk caesarean deliveries in order to enhance both infant and maternal health. The core of this programme is a learning collaborative that provides Medicaid and CHIP agencies with strategies to prevent low-risk caesarean deliveries and works directly with states to adopt research-proven best practices in their state.

Segmental Outlook

The global maternal health market is segmented by type, complication, and care. Based on type, the market is sub-segmented into intrauterine, ectopic, tubal, and others. Based on the complications, the market is sub-segmented into miscarriage, premature labor and birth, preeclampsia, gestational diabetes, placenta previa, and others. Further, on the basis of care, the market is sub-segmented into prenatal care and postnatal care. Among the complications, the miscarriage sub-segment is anticipated to hold a considerable share of the market owing to the growing demand for maternal health care as a result of an increase in miscarriages across the globe. For instance, in 2022, according to the National Institute of Health (NIH), The probability of miscarriage in women aged 20 to 30 at fewer than 20 weeks' gestation is 8.9%. When it comes to women over 40, this rises to 74.7%. Prior obstetrical history is a significant predictor of early pregnancy loss risk. After one loss, two consecutive miscarriages, or three or more consecutive miscarriages, the chance of miscarriage in a subsequent pregnancy is approximately 20%, 28%, and 43%, respectively.

The Gestational Diabetes Sub-Segment is Anticipated to Hold a Considerable Share of the Global Maternal Health Market

Among the complications, the gestational diabetes sub-segment is expected to hold a considerable share of the global maternal health market. The segmental growth is attributed to growing prevalence of gestation diabetes among population across the region. Gestational diabetes can be controlled with diet, exercise, and, in some cases, insulin therapy, depending on the severity. A chronic (long-lasting) medical condition called diabetes affects how the body converts food into energy. The goal of gestational diabetes treatment is to maintain blood glucose levels that are comparable to those of pregnant women without the condition. Special meal regimens, regular exercise schedules, daily blood glucose tests, and insulin injections are all part of the treatment. According to the Centers for Disease Control and Prevention, if a woman is not suffering from diabetes, she can develop gestational diabetes during pregnancy. Gestational diabetes affects somewhere between 2% and 10% of pregnancies each year in the US. Maintaining control of gestational diabetes ensures a safe pregnancy and a healthy delivery.

Regional Outlook

The global Maternal Health market is further segmented based on geography, including North America (the US and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and the Rest of Asia), and the Rest of the World (the Middle East and Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the increase in public health consciousness and a rise in demand for innovative medical technologies.

The North America Region is Expected to Grow at a Significant CAGR in the Global Maternal Health Market

Among all regions, North America is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to growing demand for family planning across the region. Women who possess the opportunity to utilize contraception and family planning services can space their pregnancies and lower their risk of difficulties. Accordingly, market players are coming up with new products to cater to the demand for maternal death rates. According to the Centers for Disease Control and Prevention, this report updates an earlier one that showed maternal death rates for the years 2018 to 2020. In the US, 1,205 women passed away owing to pregnancy-related causes in 2021, as opposed to 861 in 2020 and 754 in 2019. Compared to rates of 23.8 deaths per 100,000 live births in 2020 and 20.1 deaths per 100,000 live births in 2019, the maternal mortality rate for 2021 was 32.9. In 2021, non-Hispanic Black (thus, Black) women had a maternal mortality rate of 69.9 deaths per 100,000 live births, that was 2.6 times higher than the rate for non-Hispanic White (thus, White) women (26.6). Black women's rates were significantly higher than those of White and Hispanic women. Between 2020 and 2021, there were significant increases in individuals of Hispanic heritage and all other racial groups.

In 2018, the maternal mortality rate was 17.4 deaths per 100,000 live births, in 2019 it was 20.1 deaths per 100,000 live births, in 2020 it was 23.8 deaths per 100,000 live births, and in 2021 it was 32.9 deaths per 100,000 live births.

Market Players Outlook

The major companies serving the Maternal Health market include: Agile Therapeutics, Inc., Boston MedTech Advisors, Inc., Fuji Latex Co., Ltd., Johnson & Johnson Services, Inc., March of Dimes and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2022, The New Jersey Health Care Quality Institute, in partnership with the Burke Foundation, launched the Maternal Infant Health (MIH) Hub, an innovative policy and learning partnership with a mission to advance midwifery practice in New Jersey while enhancing maternal/infant health and reducing racial/ethnic inequities.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global maternal health market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Agile Therapeutics, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Boston MedTech Advisors, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. MCH Ventures, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Maternal Health Market by Type
    • 4.1.1. Intrauterine
    • 4.1.2. Ectopic
    • 4.1.3. Tubal
    • 4.1.4. Others (Intra-Abdominal Pregnancy, Singlet Pregnancy, Multiple Pregnancy)
  • 4.2. Global Maternal Health Market by Complication
    • 4.2.1. Miscarriage
    • 4.2.2. Premature Labor & Birth
    • 4.2.3. Preeclampsia
    • 4.2.4. Gestational Diabetes
    • 4.2.5. Placenta Previa
    • 4.2.6. Others (Severe Bleeding, and Infections)
  • 4.3. Global Maternal Health Market by Care
    • 4.3.1. Prenatal Care
    • 4.3.2. Postnatal Care

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Apollo Hospitals Enterprise Ltd.
  • 6.2. Ann & Robert H. Lurie Children's Hospital of Chicago
  • 6.3. Cincinnati Children's Hospital Medical Center
  • 6.4. Fuji Latex Co., Ltd.
  • 6.5. Jiovio Healthcare
  • 6.6. Johnson & Johnson Services, Inc.
  • 6.7. March of Dimes
  • 6.8. McKinsey & Co.
  • 6.9. MedTech Boston
  • 6.10. Merck & Co., Inc.
  • 6.11. Okamoto Industries Co., Ltd.
  • 6.12. RAND Corp.
  • 6.13. Reckitt Benckiser Group
  • 6.14. Sanofi